Urdu Version of Oxford Shoulder Score Scale: Reliability and Validity Study
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jun 20, 2022
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
The English version of the Oxford Shoulder Score Scale will be translated and culturally modified into Urdu. The Oxford Shoulder Score Scale, as well as other correlation measures, will be disseminated among 104 individuals in the Pakistani Urdu speaking community, who will be chosen using a convenience sample approach and based on pre-defined inclusion and exclusion criteria. For the intra- and inter-observer validity and reliability of the Oxford Shoulder Score Scale, Shoulder Pain And Disability Index, and Short Form - 36, questionnaires will be filled on the same day by two observers, w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 18 years
- • Documented cognitive impairment
- • Patient with shoulder instability
- • Acute traumatic shoulder injury
- Exclusion Criteria:
- • Age under 18 years
- • Recent surgery
- • Pain origination from neoplasms
- • Systemic arthritic
Trial Officials
Muhammad Kashif
Study Chair
Riphah International University
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Faisalabad, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials